¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£¾ÏÇÐȸ Á¦18Â÷ Á¤±âÇмú´ëȸ-Liver Cancer without Borders : 2024-04-05

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ°£¾ÏÇÐȸ Á¦18Â÷ Á¤±âÇмú´ëȸ-Liver Cancer without Borders : 2024-04-05
±³À°ÀÏÀÚ : 2024-04-05
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1, Room2

±³À°ÁÖÁ¦ : ´ëÇÑ°£¾ÏÇÐȸ Á¦18Â÷ Á¤±âÇмú´ëȸ-Liver Cancer without Borders

ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : ¿ÀÀ±Àç ´ë¸®
¿¬¶ôó : 02-373-1005  

À̸ÞÀÏ : klca@hbni.co.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú

Âü¼®¿¹»óÀÎ : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 10 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í -»çÀüµî·Ï: Æò»ý,Á¤È¸¿ø 4¸¸¿ø / ºñȸ¿ø 5¸¸¿ø / ÀüÀÓÀÇ,Àü°øÀÇ,±ºÀÇ°ü,°£È£»ç 2¸¸¿ø-ÇöÀåµî·Ï: Æò»ý,Á¤È¸¿ø 5¸¸¿ø / ºñȸ¿ø 6¸¸¿ø / ÀüÀÓÀÇ,Àü°øÀÇ,±ºÀÇ°ü,°£È£»ç 3¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 08:45~08:55 ÀÚÀ¯ ¿¬Á¦ 1 Diagnostic Biomarker Á¶ÀºÁÖ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 08:55~09:05 ÀÚÀ¯ ¿¬Á¦ 2 Predictive Surgery °­¿ìÇü(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:05~09:15 ÀÚÀ¯ ¿¬Á¦ 3 Intervention and Ablation Â÷µ¿ÀÍ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:15~09:25 ÀÚÀ¯ ¿¬Á¦ 4 Locoregional vs. Systemic Therapy Á¶À¯¸®(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:25~09:35 ÀÚÀ¯ ¿¬Á¦ 5 Molecular- and Radio-Pathology Àü¿µ½Ä(KIST)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:35~09:45 ÀÚÀ¯ ¿¬Á¦ 6 Radiotherapy À¯Á¤ÀÏ(¼º±Õ°üÀÇ´ë)

ÈÞ½Ä 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 09:45~10:00 Coffee Break .(.)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 10:00~10:30 Genetic Insights for HCC Risk Stratification in Cirrhosis Jessica Zucman-Rossi(ILCA)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 10:30~10:50 How to Evaluate Treatment Response of HCC Post-Systemic Therapy Jeong Min Lee(KLCA)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 10:50~11:10 The Evolving Therapeutic Landscape in HCC: A 10-Year Perspective Tim Meyer(ILCA)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 11:10~11:30 Multimodal and Combination Therapy for Advanced HCC Jeong Won Jang(KLCA)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 11:30~11:50 Combination Immunotherapy for Intrahepatic Cholangiocarcinoma Lorenza Rimassa(ILCA)

ÈÞ½Ä 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 11:50~12:45 Lunch Break .(.)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 12:45~13:25 2024 KLCA Practical Guidance of RFA: Expert Consensus À̵¿È£(´ëÇÑ°£¾ÏÇÐȸ ¿¬±¸ÀÌ»ç)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 13:25~13:55 Advanced Surgical Techniques and Innovations for Living Donors and Recipients ¼­°æ¼®(¼­¿ïÀÇ´ë)

ÈÞ½Ä 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 13:55~14:05 Coffee Break .(.)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:05~14:20 Novel Energies and Powers for Ablation in HCC ±è¼Ò¿¬(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:20~14:35 Technical Challenges and Opportunities in Interventional Therapies for HCC ÃÖÁø¿ì(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:35~14:50 Exploring the Potential of Carbon-Ion Radiation Therapy (CIRT) ÀÌÀÍÀç(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 14:50~15:05 Beyond Traditional Boundaries: Robotic Surgery ±è°ü¿ì(µ¿¾ÆÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 15:05~15:20 Recent Advances and Future Directions in Immune-Based Therapies for HCC ÀÌÀ±ºó(¼­¿ïÀÇ´ë)

±âŸ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 15:20~16:20 Oral Poster Presentation .(.)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:20~16:30 ÀÚÀ¯ ¿¬Á¦ 7 Challenge of HCC with or without Driver Molecules/Genes ¾ÈÁöÇö(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:30~16:40 ÀÚÀ¯ ¿¬Á¦ 8 Biomarkers-Guided Systemic Therapies for ICC Á¶Àη¡(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:40~16:55 Case Studies - Molecular Liver Cancer Conclave ÇÑÁö¿ø(°¡Å縯ÀÇ´ë)

Åä·Ð 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room1 16:55~17:20 Panel and Floor Discussion ±èÁöÈÆ,ÁÖµ¿Áø,À̹οì,Çöµ¿È£,À±»ó¹Î,±èÇý·É(°í·ÁÀÇ´ë, ¿¬¼¼ÀÇ´ë, ¼º±Õ°üÀÇ´ë, ¿ï»êÀÇ´ë, ¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 08:45~09:00 °£¾ÏÀûÁ¤¼º Æò°¡-½Ã¼ú¿µ¿ªÁöÇ¥ °³¹ß¿¬±¸ º¸°í ¾çÇö(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 09:00~09:15 ÀÓ»óÇöÀå¿¡¼­ °£¾Ï Àü½ÅÇ×¾ÏÁ¦ »ç¿ë À̽´ À±¾ÆÀϸ°(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 09:15~09:30 °£Áúȯ¿¡¼­ ÁßÁõÁúȯ »êÁ¤Æ¯·Ê Á¦µµ ¼Ò°³ ±èÁøÇö(±¹¹Î°Ç°­º¸Çè°ø´Ü)

Åä·Ð 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 09:30~09:45 ÆгΠÅäÀÇ ±èÇüÁØ,ÀÌÇö¿õ,¾çÇö,À±¾ÆÀϸ°,±èÁøÇö(Áß¾ÓÀÇ´ë,¿¬¼¼ÀÇ´ë,°¡Å縯ÀÇ´ë,ÇѾçÀÇ´ë,±¹¹Î°Ç°­º¸Çè°ø´Ü)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 14:05~14:20 Precision Imaging Techniques for Early Detection of Liver Cancer ÁÖÀÌÁø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 14:20~14:40 Biomarker Breakthroughs: For Liver Cancer Diagnosis and Prognosis ÀÌ¿µ¼±(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 14:40~15:00 Understanding Pathologic Differential Diagnosis of Liver Cancer ³²ÁöÇØ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:00~15:20 Optimizing Pre- and Post-Treatment Evaluation in Liver Cancer Á¶¿µÀ±(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:20~15:35 °£¾Ï ½Ã¼ú ¹× Ç×¾Ï Ä¡·áÀü ±³À° ·ù´ã(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:35~15:50 °£¾Ï Ä¡·á (¼ö¼ú/½Ã¼ú/¹æ»ç¼±Ä¡·á) ȯÀÚÀÇ °£È£°ü¸® Á¤Çϸ²(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 15:50~16:05 Ç×¾Ï Ä¡·á ȯÀÚÀÇ °£È£°ü¸® Á¤ÀÇÁ¤(¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:05~16:20 °£¾ÏȯÀÚÀÇ Á¤¼­Àû ÁöÁö °­¿ø¼·(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:20~16:35 Navigating Optimal Transarterial Treatments for Liver Cancer ±Ç·Á¹Î(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:35~16:50 Practical Recommendation for Local Ablation of Liver Cancer °­Å¿í(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 16:50~17:05 Surgical Strategies in Liver Cancer: A Comprehensive Approach À̽Âȯ(°æÈñÀÇ´ë)

±³À°½Ã°£ 04¿ù 05ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5F ±×·£µåº¼·ë Room2 17:05~17:20 Immunotherapy in Liver Cancer and Upcoming Challenges À¯Á¤ÁÖ(¼øõÇâÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£¾ÏÇÐȸ Á¦18Â÷ Á¤±âÇмú´ëȸ-Liver Cancer without Borders : 2024-04-05""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼÒÈ­±â±â´É¼ºÁúȯ¹×¿îµ¿ÇÐȸ APNM 2024 (11th Asian Postgraduate Course on Neurogastroenterology and Motility in conjunction with the 35th Annual Conference of the Korean Society of Neurogastroenterology and Motility) (1ÀÏÂ÷) : 2024-04-05
´ÙÀ½±Û 2024 ´ëÇÑ»ý¹°Á¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-04-05
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 76 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 39 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 45 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 34 2024-04-17
20463 ¼­¿ï 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-26 0 21 2024-04-17
20462 ¼­¿ï ´ëÇÑÃæ°ÝÆÄÄ¡·áÇÐȸ 2024 Ãá°è Çмú´ëȸ : 2024-05-26 0 21 2024-04-17
20461 ¼­¿ï Áø´Ü ü°èÀû¹®Çå°íÂû ¿öÅ©¼¥ : 2024-05-25 0 30 2024-04-17
20460 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦17ȸ ODOT (One Day Course of Obesity Treatment) : 2024-05-25 0 23 2024-04-17
20459 ¼­¿ï 2024³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-05-24 0 14 2024-04-17
20458 ¼­¿ï 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24 0 28 2024-04-17
20457 ¼­¿ï 2024³â ¿µµîÆ÷±¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-21 0 31 2024-04-17
20456 ¼­¿ï 2024³â ´ëÇÑÀÓ»ó°Ç°­ÁõÁøÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-19 0 30 2024-04-17
20455 ¼­¿ï Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 38 2024-04-17
20454 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-05-18 0 26 2024-04-17
20453 ¼­¿ï 2024³â ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¦14ȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 31 2024-04-17
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷